Exact Sciences acquires two cancer detection companies
Madison-based Exact Sciences said Tuesday it’ll buy a healthcare company dedicated to early cancer screening for around $2.2 billion.
Madison-based Exact Sciences said Tuesday it’ll buy a healthcare company dedicated to early cancer screening for around $2.2 billion.